Abstract
DART nanoparticles overcome critical drug delivery barriers for primary tumors and brain metastases.
Funding Information
  • National Institutes of Health (R37 CA218617)
  • National Institutes of Health (R01NS107813)

This publication has 59 references indexed in Scilit: